ClinicalTrials.gg
Not yet recruitingNCT03328455Updated May 1, 2026

The Role of GABA-mediated Inhibition in Multisensory Temporal Processing & Postural Control in Older Adults

An interventional study of Inhibitory control training and Knowledge-based training in Healthy Aging, sponsored by University of Nevada, Reno. Not yet recruiting. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Nevada, Reno · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

In recent years evidence has accumulated on the association between age-related decline in multisensory temporal processing and postural control. This proposed project aims at examining GABA-mediated inhibition as the potential mechanism behind this link. Our overarching hypothesis is that changes in the excitatory-inhibitory balance with a reduction of GABAergic inhibition is a common mechanism underlying age-related multisensory and postural deficits potentially mediated by age-related reduction in network segregation. To test this hypothesis, we will assess the relationship between age-related multisensory/postural deficits and age-related reduction in GABA concentration in related brain areas and probe the role of GABA-mediated inhibition using cognitive training that specifically targets inhibitory functions. Our multimodal approach is innovative, and findings from this study has the potential to lead to the development of safe and effective rehabilitation protocols for older adults with impaired multisensory temporal integration and postural control.

Read the detailed description

The investigators will examine the effects of cognitive training in the elderly on multisensory temporal processing and postural control. The investigators will include 25 young participants and use their performance to establish age-related differences and target performance for training in the elderly. 50 elderly participants will be randomly assigned to one of the two training groups and will be asked to undergo 20 days (\~30 mins/day) of inhibitory control training or knowledge-based training. Multisensory temporal processing abilities, postural stability and gait performance, brain GABA concentration, and resting-state based network segregation will be assessed before and immediately after training. Follow-up assessments will be carried out 30 days after training to examine the persistence of training effects.

Stimulus presentation. Visual and auditory stimuli will be generated using MATLAB and the psychophysics toolbox. Visual and auditory stimuli will be delivered via Display++ system and an AudioFile stimulus processor, respectively (Cambridge Research Systems). The use of these two devices allows for precise control of stimulus timing.

Inhibitory control training. Participants will be trained with tasks that involve both response withholding and rule switching. For example, participants will be asked to sort polygons based on features (e.g., shape or color) and will be asked to either provide or withhold sorting responses when presented with different cues. Rule-switching is introduced when participants must inhibit the "rule" used in the previous trial set and change the focus of their attention to a new sorting and/or inhibitory rule.

Knowledge-based training. This condition serves as the control. Participants will be presented with questions from different categories such as vocabulary, science, or geography and asked to select the correct answer from 4 alternatives within a certain time limit.

In both training conditions, task difficulty will progressively increase over the course of training based on participants' abilities. Pre- and post-training assessment of multisensory temporal processing abilities, postural stability and gait performance, brain GABA concentration, and resting-state based network segregation will be conducted.

02

Conditions studied

  • Healthy Aging
03

In context

Lead sponsor

University of Nevada, Reno is the lead sponsor of 28 studies on the registry; 5 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 65 and 80 (elderly group) and between 20 and 35 (young group)

Exclusion criteria

Exclusion Criteria:

  • History of epilepsy, stroke, Parkinson's disease, Alzheimer's disease, attention deficit-hyperactivity disorder
  • History of head injury with loss of consciousness, brain surgery, or psychiatric disorders
  • Early dementia or cognitive impairment
  • Serious vision problems (including best-corrected binocular visual acuity worse than 20/25)
  • Uncorrected hearing problems (pure tone threshold > 40 dB for 1000-2000 Hz)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Inhibitory control training

    In the inhibitory control training condition, participants will be trained with tasks that involve both response withholding and rule switching. For example, participants will sort polygons based on features (e.g., shape or color) and will be asked to either provide or withhold sorting responses when presented with different cues. Rule-switching is introduced when participants must inhibit the "rule" used in the previous trial set and change the focus of their attention to a new sorting and/or inhibitory rule. Task difficulty will progressively increase over the course of training based on participants' abilities.

    Behavioral: Inhibitory control training

  • Sham comparator
    knowledge-based training

    The knowledge-based training condition serves as the control, in which participants will be presented with questions from different categories such as vocabulary, science, or geography and asked to select the correct answer from 4 alternatives within a certain time limit. Task difficulty will progressively increase over the course of training based on participants' abilities.

    Behavioral: Knowledge-based training

Interventions

  • BehavioralInhibitory control training

    Cognitive training is inhibitory task-related.

  • BehavioralKnowledge-based training

    Training is not inhibitory task-related.

06

What researchers measure

Primary outcomes

  1. Multisensory temporal processing performance change

    Change from pre-training performance

    Time frame: At the end of 20-day training

  2. Multisensory temporal processing performance change maintenance

    Change from pre-training performance

    Time frame: 30 days after training

  3. Postural control and gait performance change

    Change from pre-training performance

    Time frame: At the end of 20-day training

  4. Postural control and gait performance change maintenance

    Change from pre-training performance

    Time frame: 30 days after training

  5. Brain GABA level change

    Change from pre-training level

    Time frame: At the end of 20-day training

  6. Brain GABA level change maintenance

    Change from pre-training level

    Time frame: 30 days after training

  7. Resting-state network segregation change

    Change from pre-training level

    Time frame: At the end of 20-day training

  8. Resting-state network segregation change maintenance

    Change from pre-training level

    Time frame: 30 days after training

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Results from proposed experiments will be reported either as group findings that do not identify individual participants, or by labeling the data of each participant with a unique code that does not include the participant's name or initials. De-identified individual participant data will be shared upon request and for research purpose only starting 1 year after publication.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Starting 1 year after publication

Access criteria: Data will be shared upon request and for research purpose only.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2027; primary completion for Nov 2030, 35 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2017
First posted
Nov 1, 2017
StartEst.
Dec 1, 2027
Primary completionEst.
Nov 30, 2030
CompletionEst.
Nov 30, 2031
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03328455
Lead sponsor
University of Nevada, Reno
Responsible party
Fang Jiang (Associate professor, University of Nevada, Reno) — Principal investigator
First posted
Nov 1, 2017
Start date
Dec 1, 2027 (estimated)
Primary completion
Nov 30, 2030 (estimated)
Completion
Nov 30, 2031 (estimated)
Last update
May 1, 2026

Study contacts

Fang Jiang, Ph.D
Contact
fangj@unr.edu
775-682-8606
Fang Jiang, Ph.D
principal investigator · University of Nevada, Reno

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion